ACCESSING CLASSIFIED FILES
Decrypting documents...
Your connection is being monitored
ACCESSING CLASSIFIED FILES
Decrypting documents...
Your connection is being monitored

Former U.S. Secretary of Health and Human Services
HHS Secretary 2018-2021, Former Eli Lilly Executive
Alex Azar served as HHS Secretary during the COVID-19 pandemic after previously working as a top executive at Eli Lilly where drug prices increased significantly. He oversaw the disastrous early pandemic response and was sidelined in favor of the White House coronavirus task force. He resigned after January 6. Investigation into Alex Michael Azar II is ongoing, with connections to multiple entities under scrutiny. This entry is being expanded as new evidence surfaces through public records analysis and investigative journalism.
Drug prices tripled at Eli Lilly during his tenure
Failed early COVID-19 response
Sidelined by White House during pandemic
Conflicts of interest from pharma background
Family separation policy implementation
Resigned after January 6 but did not invoke 25th
7 documented violations
18 U.S.C. § 20842 U.S.C. § 247d (Public Health Emergencies)6 U.S.C. § 279 (Unaccompanied Alien Children)8 U.S.C. § 1232 (Trafficking Victims Protection)21 U.S.C. § 360bbb-3 (Emergency Use Authorization)5 U.S.C. § 333142 C.F.R. Part 73 (Select Agents)Cabinet member
HHS oversaw NIAID
1 documented sources from official records, investigations, and reports
2018
January: Confirmed as HHS Secretary
2020
January: First U.S. COVID case detected
2020
February: Sidelined on COVID response
2021
January: Resigns